Preserved cognition and reduced age-related cognitive decline during treatment with angiotensin II receptor blockers: A 20-year follow-up study

痴呆 医学 认知功能衰退 前瞻性队列研究 逻辑回归 内科学 优势比 人口 认知 横断面研究 风险因素 比例危险模型 疾病 精神科 病理 环境卫生
作者
Dominik Wincewicz,Tommi Tolmunen,Anna‐Katharine Brem,Jussi Kauhanen,Seppo Lehto
出处
期刊:European Psychiatry [Cambridge University Press]
卷期号:41 (S1): S372-S372 被引量:2
标识
DOI:10.1016/j.eurpsy.2017.02.386
摘要

Introduction Modulators of the brain renin-angiotensin system (RAS) have been shown to improve cognitive functioning in several animal models of neuropsychiatric disorders. Moreover, the brain RAS has been considered a new target for the treatment of Alzheimer's disease (AD). However, there are no population-based follow-up studies supporting this hypothesis. Objectives Cross-sectional and prospective relationships between cognitive decline and ARB treatment were examined in the population-based Kuopio Ischemic Heart Disease Risk Factor Study. Aims To evaluate procognitive/antidementia capacity of orally delivered angiotensin II receptor blockers (ARB). Methods The study was conducted on a sample of 1774 subjects (920 females, 854 males; age range at baseline: 42–61 years) from Eastern Finland. An established cutoff score of at least 2-point decrease in the Mini Mental State Examination over a 9-year follow-up was used to detect age-related cognitive decline in the cross-sectional setting. In the prospective setting, a hospital discharge diagnosis of dementia/AD was used as outcome variable. Cross-sectional relationships were determined with logistic regression and prospective analyses were conducted with the Cox proportional hazards model (both adjusted for relevant background variables). Results Cross-sectional analysis displayed a decrease of the odds of cognitive decline ( n = 87; 4.9% of participants) in those with ARB treatment; OR = 0.445, 95% CI: 0.22–0.90, P = 0.024. Furthermore, in the prospective setting, the risk of dementia/AD diagnosis ( n = 149; 8.4% of participants) was significantly reduced in ARB treated participants; HR = 0.621, 95% CI: 0.40–0.98, P = 0.038. Conclusions ARB treatment is associated with a decreased risk for age-related cognitive decline and dementia/AD manifestation. Disclosure of interest The authors have not supplied their declaration of competing interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今天学习了吗完成签到 ,获得积分10
1秒前
1秒前
xyq发布了新的文献求助10
1秒前
Rose发布了新的文献求助10
1秒前
1秒前
非烟发布了新的文献求助10
1秒前
求助人员发布了新的文献求助30
2秒前
石人达完成签到,获得积分10
2秒前
2秒前
小桃子完成签到,获得积分10
2秒前
慕青应助zhuzhu采纳,获得10
2秒前
糖豆发布了新的文献求助20
3秒前
jajaqy发布了新的文献求助10
3秒前
凡凡发布了新的文献求助10
3秒前
秦翠翠发布了新的文献求助30
4秒前
万能图书馆应助孙漪采纳,获得10
4秒前
4秒前
大花花完成签到,获得积分10
4秒前
CipherSage应助XX采纳,获得10
4秒前
三岁居居发布了新的文献求助10
4秒前
Overlord完成签到 ,获得积分10
4秒前
小羊烧鸡发布了新的文献求助10
4秒前
三七发布了新的文献求助10
4秒前
前前发布了新的文献求助50
4秒前
锕系第八元素完成签到,获得积分10
5秒前
hi完成签到,获得积分10
5秒前
量子星尘发布了新的文献求助10
5秒前
5秒前
5秒前
香蕉觅云应助wzx采纳,获得10
6秒前
浮游应助Sunny采纳,获得10
6秒前
fantexi113完成签到,获得积分10
6秒前
gao完成签到,获得积分10
6秒前
夏夏发布了新的文献求助10
6秒前
浮游应助FlipFlops采纳,获得10
6秒前
乐乐应助xyq采纳,获得10
6秒前
巫马垣完成签到,获得积分10
6秒前
研友_VZG7GZ应助饱满的鸡翅采纳,获得10
6秒前
甜美的尔岚应助chase采纳,获得30
6秒前
张锐斌完成签到,获得积分10
7秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 12000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
Advanced Memory Technology: Functional Materials and Devices 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5691791
求助须知:如何正确求助?哪些是违规求助? 5085965
关于积分的说明 15206222
捐赠科研通 4849432
什么是DOI,文献DOI怎么找? 2601032
邀请新用户注册赠送积分活动 1552781
关于科研通互助平台的介绍 1511181